Form 4 for NSPR InspireMD, Inc.
Accepted 2023-08-30 00:00:00 ET · period of report 2023-08-28 · accession 0001493152-23-030663 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-30 | 2023-08-28 | NSPR | Gleason Shane Thomas | Chief Commercial Off | A - Grant | $0.00 | +19.3K | 275.7K | +8% | $0 |
| D | 2023-08-30 | 2023-08-28 | NSPR | Gleason Shane Thomas | Chief Commercial Off | A - Grant | $0.00 | +6,430 | 91.9K | +8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-28 | A | A | 19,290 | $0.00 | 275,740 | D | — | — | (F1) These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of August 28, 2024, August 28, 2025 and August 28, 2026, subject to the Reporting Person's continued service. |
| 2 | Derivative | Options to purchase common stock (right to buy) | 2023-08-28 | A | A | 6,430 | $0.00 | 91,910 | D | $3.37 · — to 2033-08-28 | 6,430 Common Stock | (F2) The options vest and become exercisable in three equal installments, with 1/3 vesting on each of August 28, 2024, August 28, 2025 and August 28, 2026, subject to the Reporting Person's continued service. |